Results from B-AMAZE, A Phase 1/2 study by Freeline Therapeutics on FLT180a, was presented at the American Society of Hematology from...

Giroctocogene fitelparvovec, with the newest groundbreaking results coming out, prevents bleeding in men with severe hemophilia A for at...

Subcutaneous infusions are on the rise as medical technology advances and pharmaceutical companies learn more. Fitusiran, called...